Literature DB >> 12444490

The uptake machinery of clostridial actin ADP-ribosylating toxins--a cell delivery system for fusion proteins and polypeptide drugs.

Holger Barth1, Dagmar Blöcker, Klaus Aktories.   

Abstract

Several bacterial protein toxins, including Clostridium botulinum C2 toxin, Clostridum perfringens iota toxin, Clostridium difficile ADP-ribosyltransferase, and the Bacillus-produced vegetative insecticidal proteins, target the cytoskeleton by ADP-ribosylation of actin. All these toxins are binary in structure and consist of an enzyme component, possessing ADP-ribosyltransferase activity and a separated binding and translocation component, which is involved in the delivery of the enzyme component into the cell. The toxins are not only important virulence factors but also cell biological tools to study the function of the actin cytoskeleton. Moreover, the binary toxins turned out to be effective transporter systems for the delivery of specific fusion toxins (e.g., Rho-ADP-ribosylating C3 exoenzyme) into cells. The present review describes the biological functions of the toxins, focuses on recent studies on the uptake and delivery mechanism and discusses the usage as a drug delivery system.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12444490     DOI: 10.1007/s00210-002-0626-y

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  16 in total

1.  The host cell chaperone Hsp90 is necessary for cytotoxic action of the binary iota-like toxins.

Authors:  Gerd Haug; Klaus Aktories; Holger Barth
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

2.  Anthrax toxin protective antigen: inhibition of channel function by chloroquine and related compounds and study of binding kinetics using the current noise analysis.

Authors:  Frank Orlik; Bettina Schiffler; Roland Benz
Journal:  Biophys J       Date:  2004-12-13       Impact factor: 4.033

3.  Pasteurella multocida toxin as a transporter of non-cell-permeating proteins.

Authors:  Stefan Bergmann; Doris Jehle; Carsten Schwan; Joachim H C Orth; Klaus Aktories
Journal:  Infect Immun       Date:  2013-04-29       Impact factor: 3.441

Review 4.  Botulinum toxins--cause of botulism and systemic diseases?

Authors:  H Böhnel; F Gessler
Journal:  Vet Res Commun       Date:  2005-05       Impact factor: 2.459

Review 5.  Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins.

Authors:  Holger Barth; Klaus Aktories; Michel R Popoff; Bradley G Stiles
Journal:  Microbiol Mol Biol Rev       Date:  2004-09       Impact factor: 11.056

6.  Role of small GTPase Rho in regulating corneal epithelial wound healing.

Authors:  Jia Yin; Jinshuang Lu; Fu-Shin X Yu
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-03       Impact factor: 4.799

7.  Role of N-terminal His6-Tags in binding and efficient translocation of polypeptides into cells using anthrax protective antigen (PA).

Authors:  Christoph Beitzinger; Caroline Stefani; Angelika Kronhardt; Monica Rolando; Gilles Flatau; Emmanuel Lemichez; Roland Benz
Journal:  PLoS One       Date:  2012-10-08       Impact factor: 3.240

8.  Cross-reactivity of anthrax and C2 toxin: protective antigen promotes the uptake of botulinum C2I toxin into human endothelial cells.

Authors:  Angelika Kronhardt; Monica Rolando; Christoph Beitzinger; Caroline Stefani; Michael Leuber; Gilles Flatau; Michel R Popoff; Roland Benz; Emmanuel Lemichez
Journal:  PLoS One       Date:  2011-08-05       Impact factor: 3.240

Review 9.  Clostridial binary toxins: iota and C2 family portraits.

Authors:  Bradley G Stiles; Darran J Wigelsworth; Michel R Popoff; Holger Barth
Journal:  Front Cell Infect Microbiol       Date:  2011-12-01       Impact factor: 5.293

10.  Difference in F-actin depolymerization induced by toxin B from the Clostridium difficile strain VPI 10463 and toxin B from the variant Clostridium difficile serotype F strain 1470.

Authors:  Martin May; Tianbang Wang; Micro Müller; Harald Genth
Journal:  Toxins (Basel)       Date:  2013-01-11       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.